Tagtociclib (PF-07104091)

规格	库存	目录价	会员专享价	数量
暂无牌价信息，您可以发送询价，我们会尽快给你回复。

规格

库存

目录价

会员专享价

数量

暂无牌价信息，您可以发送询价，我们会尽快给你回复。

基本信息

英文名称	Tagtociclib (PF-07104091)
中文名称	(1R,3S)-3-(5-(3-(甲氧基甲基)-1-甲基-1H-吡唑-5-甲酰胺基)-1H-吡唑-3-基)环戊基异丙基氨基甲酸酯
CAS号	2460249-19-6
分子式	C19H28N6O4
分子量	404.46
外观	Solid powder
储存条件	Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years).

产品详情

Tagtociclib, also known as PF-07104091, is an orally bioavailable inhibitor of cyclin-dependent kinase 2 (CDK2), with potential antineoplastic activity. Upon administration, CDK2 inhibitor PF-07104091 selectively targets, binds to and inhibits the activity of CDK2. This may lead to cell cycle arrest, the induction of apoptosis, and the inhibition of tumor cell proliferation. CDKs are serine/threonine kinases that are important regulators of cell cycle progression and cellular proliferation and are frequently overexpressed in tumor cells. CDK2/cyclin E complex plays an important role in retinoblastoma (Rb) protein phosphorylation and the G1-S phase cell cycle transition. CDK2/cyclin A complex plays an important role in DNA synthesis in S phase and the activation of CDK1/cyclin B for the G2-M phase cell cycle transition.

(1R,3S)-3-(5-(3-(甲氧基甲基)-1-甲基-1H-吡唑-5-甲酰胺基)-1H-吡唑-3-基)环戊基异丙基氨基甲酸酯

Tagtociclib (PF-07104091)

化学品安全说明书(MSDS)

质检证书(COA)